AstraZeneca: Stomach Ulcer trials

The registry lists 17 Stomach Ulcer studies with AstraZeneca as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 3 11Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCompletedNCT03553563Phase 3Results posted
• A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesCompletedNCT02153398Phase 3Results posted
• Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose AspirinCompletedNCT01069939Phase 3Results posted
• Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced UlcerCompletedNCT00595517Phase 3Results posted
• Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDCompletedNCT00542789Phase 3Results posted
• Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)CompletedNCT00441727Phase 3Results posted
• Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric UlcerCompletedNCT00401752Phase 3Results posted
• BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsCompletedNCT01964131Phase 1
• Nexium Capsules LDA Specific Clinical Experience InvestigationCompletedNCT01729182
• Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience InvestigationCompletedNCT01562600
• Nexium Capsules Helicobacter Pylori Specific Clinical Experience InvestigationCompletedNCT01435525
• Nexium Capsules Clinical Experience InvestigationCompletedNCT01434485
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is ContinuedCompletedNCT00633672Phase 3
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US OnlyCompletedNCT00633412Phase 3
• Ulcer Prevention IICompletedNCT00629928Phase 3
• Prevention of Gastric UlcersCompletedNCT00629512Phase 3
• An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving NexiumCompletedNCT00428701Phase 4